Biomind Labs (FRA:3XI) Retained Earnings : €-13.57 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Biomind Labs's retained earnings for the quarter that ended in Sep. 2024 was €-13.57 Mil.

Biomind Labs's quarterly retained earnings declined from Mar. 2024 (€-13.63 Mil) to Jun. 2024 (€-13.96 Mil) but then increased from Jun. 2024 (€-13.96 Mil) to Sep. 2024 (€-13.57 Mil).

Biomind Labs's annual retained earnings declined from Dec. 2021 (€-9.25 Mil) to Dec. 2022 (€-12.68 Mil) and declined from Dec. 2022 (€-12.68 Mil) to Dec. 2023 (€-13.41 Mil).

Biomind Labs Retained Earnings Historical Data

The historical data trend for Biomind Labs's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Retained Earnings Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

-9.25

-12.68

-13.41

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial										-13.44	-13.41	-13.63	-13.96	-13.57

Biomind Labs Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Biomind Labs (FRA:3XI) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Biomind Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (FRA:3XI) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

BMNDF:USA BMND:Canada

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs Headlines

No Headlines